Search

everythinglearnresearchcommunity

for

Search:↓

New insights into cell communication in psoriasis suggest innovative drug treatments.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Nanoliposomes effectively deliver hair-growth peptides into hair follicles.

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Nanotechnology can improve alopecia treatments but faces stability challenges.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

A new microneedle system may improve hair loss treatment by delivering ketoconazole directly to hair follicles.

Tocilizumab might be an effective treatment for COVID-19.

The bio-patch improves wound healing by reducing stress, inflammation, and promoting blood vessel growth.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

The mats help heal wounds and support bone growth while controlling infections.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Six months after COVID-19, most patients still had autoantibodies.

A new mouse model helps understand and find treatments for alopecia areata.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Smaller mesoporous nanoparticles can improve the effectiveness of topical drugs by penetrating skin furrows.

AIMP1 can boost hair growth by increasing stem cell activity.

Adding a second method to PROTACs could improve cancer treatment.

Certain substances can help skin cells become anti-inflammatory, aiding in tissue repair.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.